Synopsis:
The firm secured a USD 7.8 million international turnkey MEP contract, boosting sentiment amid strong Q2 results and a sharp jump in profit. With a robust global footprint, diversified orders, and proven execution, the company continues to strengthen its position in high-growth engineering markets.
The shares of the pharma plant solutions provider gained up to 4 percent in today’s trading session after the company secured a major international turnkey MEP contract worth USD 7.8 million.
With a market capitalization of Rs 1,119.72 crore, the shares of Fabtech Technologies Ltd were trading at Rs 250.00 per share, increasing around 1.30 percent as compared to the previous closing price of Rs 246.80 apiece.
Significant order
The shares of Fabtech Technologies Ltd have seen positive movement after securing a major international turnkey MEP contract worth USD 7.8 million (≈ Rs 65.5 crore) from a leading Saudi Arabian client. The project involves setting up cleanroom infrastructure, HVAC, MEP, and utilities for a GMP-compliant animal vaccine facility in Dammam. Execution will span 11 months from the advance payment, strengthening Fabtech’s global project footprint.
Results Highlights & Operational Highlights
Fabtech Technologies delivered a strong Q2FY26 performance, with revenue more than doubling to Rs 121 crore, up 105% year-on-year. Net profit surged sharply to Rs 28 crore from Rs 5 crore, a 460% jump. This reflects robust execution, rising order flows, and improving margins, signalling strong operational momentum for the company.
Fabtech Technologies showcases strong global credibility with ISO-certified operations and a 180+ member team, including 94+ engineers. The company has delivered 135+ projects across 62 countries and holds an order book of Rs 90,441.87 lakh as of July 2025. With three decades of expertise, it remains a trusted turnkey partner for leading pharmaceutical and biotech companies.
Fabtech Technologies’ FY25 order mix shows strong geographical diversification. MENA leads with 39% of orders, followed by the ECO Zone at 27% and GCC at 18%. SEA contributes 16%, while SADC, Europe and America remain minimal. Compared to previous years, the company is steadily expanding its presence across high-growth international markets.
Fabtech Technologies has executed diverse global projects across Palestine, Bangladesh, Saudi Arabia, and Kenya. Its work spans cleanroom installations, HVAC systems, purified water plants, isolator systems, and turnkey utilities setups. The company has also delivered warehouse automation, process equipment, ointment lines, and QC laboratories, highlighting its strong capabilities in pharma, biotech, and industrial engineering solutions worldwide.
Fabtech Technologies is a global engineering solutions provider specializing in cleanrooms, HVAC, turnkey projects, and advanced manufacturing systems for pharma and biotech industries. With three decades of expertise and a presence in many countries, the company is known for delivering high-quality, ISO-certified solutions backed by strong in-house design and execution capabilities.
Written by Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
